[
1. Celakovská J, Bukac J, Ettler K, et al. Evaluation of Peripheral Blood Eosinophilia in Adolescent and Adult Patients Suffering from Atopic Dermatitis and the Relation to the Occurrence of Allergy to Aeroallergens. Indian J Dermatol. 2019;64(1):34-40.
]Search in Google Scholar
[
2. Mier PD. Earliest description of the atopic syndrome? Br Med J. 1975; 92:359.
]Search in Google Scholar
[
3. Unna PG. The history of eczema in the last century in England. Br Med J. 1902.
]Search in Google Scholar
[
4. Little EG. Prurigo of Hebra. Proc R Soc Med. 1908; 1:181-182.
]Search in Google Scholar
[
5. Besnier E. Première note et observations preliminaries pour servir d’introduction à l’étude diathésique. Ann Dermatol Syphiligr. 1892; 4:634.
]Search in Google Scholar
[
6. Kramer ON, Strom MA, Ladizinski B, et al. The history of atopic dermatitis. Clin Dermatol. 2017;35(4):344-348.
]Search in Google Scholar
[
7. Körting GW. Zur Pathogenese des endogenen Ekzems. Stuttgart: Thieme; 1954.
]Search in Google Scholar
[
8. Epstein WL. Sulzberger on allergy and immunology: the young lion returns to New York. Int J Dermatol. 1977;16(5):353-9.
]Search in Google Scholar
[
9. Wüthrich B. Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases. Clin Allergy. 1978;8(3):241-8.
]Search in Google Scholar
[
10. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener. 1980; 92:44-7.
]Search in Google Scholar
[
11. Horii KA, Simon SD, Liu DY, et al. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. 2007; 120(3):e527-34.
]Search in Google Scholar
[
12. Silverberg JI, Garg NK, Paller AS, et al. Sleep disturbances in adults with eczema are associated with impaired overall health: A US population-based study. J Invest Dermatol. 2015;135(1):56-66.
]Search in Google Scholar
[
13. Schmitt J, Schmitt NM, Kirch W et al. Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges. 2009; 7:345-51.
]Search in Google Scholar
[
14. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314-24.
]Search in Google Scholar
[
15. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2): 338-51.
]Search in Google Scholar
[
16. Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol. 2005;52(4):579-582.
]Search in Google Scholar
[
17. Schram ME, Tedja AM, Spijker R, et al. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol. 2010;162(5):964-973.
]Search in Google Scholar
[
18. Boulet LP. Obesity and atopy. Clin Exp Allergy. 2015;45(1):75-86.
]Search in Google Scholar
[
19. Weiland SK, Hüsing A, Strachan DP, et al. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med. 2004; 61(7):609-615.
]Search in Google Scholar
[
20. Kantor R, Kim A, Thyssen JP, et al. Association of atopic dermatitis with smoking: A systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(6):1119-1125.e1.
]Search in Google Scholar
[
21. Apfelbacher CJ, Diepgen TL, Schmitt J. Determinants of eczema: population-based cross-sectional study in Germany. Allergy. 2011; 66(2):206-13.
]Search in Google Scholar
[
22. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predis-posing factor for atopic dermatitis. Nat Genet. 2006; 38(4):441-6.
]Search in Google Scholar
[
23. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011; 365(14):1315-27.
]Search in Google Scholar
[
24. Cabanillas B, Novak N. Atopic dermatitis and filaggrin. Curr Opin Immunol. 2016;42:1-8.
]Search in Google Scholar
[
25. He JQ, Chan-Yeung M, Becker AB, et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 2003; 4(5):385-9.
]Search in Google Scholar
[
26. Toda M, Leung DY, Molet S, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol. 2003;111(4):875-81.
]Search in Google Scholar
[
27. Cevikbas F, Wang X, Akiyama T, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133 (2):448-60.
]Search in Google Scholar
[
28. Imai Y. Interleukin-33 in atopic dermatitis. J Dermatol Sci. 2019;96(1):2-7.
]Search in Google Scholar
[
29. Yamada H, Chihara J, Matsukura M, et al. Elevated plasma RANTES levels in patients with atopic dermatitis. J Clin Lab Immunol. 1996;48(2):87-91.
]Search in Google Scholar
[
30. Lee JS, Kim IS, Ryu JS, Yun CY. House dust mite, dermatophagoides pteronissinus increases expression of MCP-1, IL-6, and IL-8 in human monocytic THP-1 cells. Cytokine. 2008;42:365-371.
]Search in Google Scholar
[
31. Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018;26: 484-97.
]Search in Google Scholar
[
32. Kim KP, Shin KO, Park K, et al. Vitamin C stimulates epidermal ceramide production by regulating its metabolic enzymes. Biomol Ther. 2015;23(6):525-30.
]Search in Google Scholar
[
33. Uehara M. Infraorbital fold in atopic dermatitis. Arch Dermatol. 1981;117(10):627-9.
]Search in Google Scholar
[
34. Lancrajan C, Bumbacea R, Giurcaneanu C. Erythrodermic atopic dermatitis with late onset--case presentation. J Med Life. 2010;3(1):80-3.
]Search in Google Scholar
[
35. Hahn EL, Bacharier LB. The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am. 2005;25(2):231-246.
]Search in Google Scholar
[
36. Silverberg JI, Joks R, Durkin HG. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy. 2014;69(1):95-103.
]Search in Google Scholar
[
37. Yamazaki Y, Nakamura Y, Núñez G. Role of the microbiota in skin immunity and atopic dermatitis. Allergol Int. 2017;66(4):539-544.
]Search in Google Scholar
[
38. Juhn YJ, Frey D, Li X, Jacobson R. Streptococcus pyogenes upper respiratory infection and atopic conditions other than asthma: a retrospective cohort study. Prim Care Respir J. 2012;21(2):153-8.
]Search in Google Scholar
[
39. Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol. 2007;127(5):1261-1263.
]Search in Google Scholar
[
40. Popov Y, Nikolov R, Lalova A. Localized eczema herpeticum with unilateral ocular involvement. Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(3):35-7.
]Search in Google Scholar
[
41. Saurat JH. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol Suppl. (Stockh). 1985; 114:125-8.
]Search in Google Scholar
[
42. Estrada-Reyes E, Hernnández-Román MP, Gamboa-Marrufo JD, et al. Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity. J Investig Allergol Clin Immunol. 2008;18(2):131-5.
]Search in Google Scholar
[
43. Kilic G, Guler N, Ones U, et al. Netherton syndrome: report of identical twins presenting with severe atopic dermatitis. Eur J Pediatr. 2006;165(9):594-7.
]Search in Google Scholar
[
44. Dourmishev A, Miteva L, Mitev V, et al. Cutaneous aspects of Down syndrome. Cutis. 2000;66(6):420-4.
]Search in Google Scholar
[
45. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association „Administrative Regulations for Evidence- Based Clinical Practice Guidelines“. J Am Acad Dermatol. 2004;50(3):391-404.
]Search in Google Scholar
[
46. Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-9.
]Search in Google Scholar
[
47. Leshem YA, Hajar T, Hanifin JM, et al. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172(5):1353-7.
]Search in Google Scholar
[
48. Arbes SJ Jr, Gergen PJ, Elliot L, et al. Prevalence of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377-383.
]Search in Google Scholar
[
49. Di Lorenzo G, Gangemi S, Merendino RA, et al. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Mediators Inflamm. 2003;12(2):123-5.
]Search in Google Scholar
[
50. Fluhr JW, Zuberbier T, Darlenski R. Noninvasive measures in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2018;18(5):417-424.
]Search in Google Scholar
[
51. Werfel T, Heratizadeh A, Aberer W, et al. S2k guideline on diagnosis and treatment of atopic dermatitis – short version. Allergo J Int 2016; 25:82-95.
]Search in Google Scholar
[
52. Broeders JA, Ahmed Ali U, Fischer G. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. J Am Acad Dermatol. 2016;75(2):410-419.e3.
]Search in Google Scholar
[
53. Glatz M, Bosshard PP, Hoetzenecker W, et al. The Role of Malassezia spp. in Atopic Dermatitis. J Clin Med. 2015;4(6):1217-28.
]Search in Google Scholar
[
54. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol. 2000;25(7):552-8.
]Search in Google Scholar
[
55. Valkova S, Velkova A. UVA/UVB phototherapy for atopic dermatitis revisited. J Dermatolog Treat. 2004;15(4):239-44.
]Search in Google Scholar
[
56. Dourmishev L, Guleva D, Miteva L. Phototherapy and atopic dermatitis. MEDINFO 2016; 2: 56-60. [Article in Bulgarian]
]Search in Google Scholar
[
57. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327-49.
]Search in Google Scholar
[
58. Mrowietz U, Klein CE, Reich K et al. Cyclosporine therapy in dermatology. J Dtsch Dermatol Ges 2009; 7:474–9.
]Search in Google Scholar
[
59. Berth-Jones J, Takwale A, Tan E, et. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol. 2002;147(2):324-30.
]Search in Google Scholar
[
60. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006;367(9513):839-46.
]Search in Google Scholar
[
61. Weatherhead SC, Wahie S, Reynolds NJ, et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol. 2007;156(2):346-51.
]Search in Google Scholar
[
62. Phan K, Smith SD. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis. J Dermatolog Treat. 2020;31(8):810-814.
]Search in Google Scholar
[
63. Dourmishev L, Guleva D, Miteva L. Intravenous immunoglobulins: mode of action and indications in autoimmune and inflammatory dermatoses. Int J Inflamm 2016; ID Article ID 3523057.
]Search in Google Scholar
[
64. Duarte B, Cordeiro A, Paiva-Lopes MJ. Rituximab revisited: successful management of severe childhood atopic dermatitis. Eur J Dermatol. 2019;29(1):94-96.
]Search in Google Scholar
[
65. Khattri S, Brunner PM, Garcet S, et al. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis. Exp Dermatol. 2017;26(1):28-35.
]Search in Google Scholar
[
66. Moul DK, Routhouska SB, Robinson MR, et al. Alefacept for moderate to severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol. 2008;58(6):984-9.
]Search in Google Scholar
[
67. Holm JG, Thomsen SF. Omalizumab for atopic dermatitis: evidence for and against its use. G Ital Dermatol Venereol. 2019;154(4):480-487.
]Search in Google Scholar
[
68. Wang FP, Tang XJ, Wei CQ, et al. Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis. J Dermatol Sci. 2018; 90:190-8.
]Search in Google Scholar
[
69. Simpson EL, Bieber T, Guttman-Yassky E, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016;375(24):2335-2348.
]Search in Google Scholar
[
70. Broshtilova V, Gantcheva M. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis. Dermatol Ther. 2010;23(1):90-3.
]Search in Google Scholar
[
71. D‘Erme AM, Milanesi N, Agnoletti AF, et al. Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands. Dermatol Ther. 2014;27(1):21-3.
]Search in Google Scholar
[
72. Zhao M, Shen C, Ma L. Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: a systematic review and meta-analysis. Int J Dermatol. 2018;57(6):635-641.
]Search in Google Scholar
[
73. Dourmishev A. Department of Dermatology and Venereology. In: “Medical Faculty Sofia – 75 years” M. Apostolov (Ed.). Sofia 1993, 228-233.
]Search in Google Scholar
[
74. Berowa N, Lalova A, Botev-Zlatkov N, et al. Helio-, Klima- und Thalassotherapie des atopischen Ekzems. Thalassotherapie, XX Congressus internationalis, Borkum. May 1991:225-227.
]Search in Google Scholar
[
75. Berova N, Vidinova J, Lalova A. Atopic dermatitis. In: Climatotherapy of skin diseases. N. Zlatkov (Ed.). Sofia, Medizina i Fizkultura, 1989, 66-78. [Publication in Bulgarian]
]Search in Google Scholar
